Skip to main content
Erschienen in: Digestive Diseases and Sciences 6/2022

04.05.2021 | COVID-19 | Original Article Zur Zeit gratis

Increased Morbidity and Mortality in COVID-19 Patients with Liver Injury

verfasst von: Mohammad Arsalan Siddiqui, Suraj Suresh, Stephen Simmer, Mouhanna Abu-Ghanimeh, Megan Karrick, Faisal Nimri, Maher Musleh, Vivek Mediratta, Mustafa Al-Shammari, Sarah Russell, Jessica Jou, Duyen Dang, Reena Salgia, Tobias Zuchelli

Erschienen in: Digestive Diseases and Sciences | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

There is a high prevalence of liver injury (LI) in patients with coronavirus disease 2019 (COVID-19); however, few large-scale studies assessing risk factors and clinical outcomes in these patients have been done.

Aims

To evaluate the risk factors and clinical outcomes associated with LI in a large inpatient cohort of COVID-19 patients.

Methods

Adult patients with COVID-19 between March 1 and April 30, 2020, were included. LI was defined as peak levels of alanine aminotransferase/aspartate aminotransferase that were 3 times the ULN or peak levels in alkaline phosphatase/total bilirubin that were 2 times the ULN. Mild elevation in liver enzymes (MEL) was defined as abnormal peak liver enzyme levels lower than the threshold for LI. Patients with MEL and LI were compared to a control group comprising patients with normal liver enzymes throughout hospitalization.

Results

Of 1935 hospitalized COVID-19 patients, 1031 (53.2%) had MEL and 396 (20.5%) had LI. Compared to control patients, MEL and LI groups contained proportionately more men. Patients in the MEL cohort were older compared to control, and African-Americans were more highly represented in the LI group. Patients with LI had an increased risk of mortality (relative risk [RR] 4.26), intensive care unit admission (RR, 5.52), intubation (RR, 11.01), 30-day readmission (RR, 1.81), length of hospitalization, and intensive care unit stay (10.49 and 10.06 days, respectively) compared to control.

Conclusion

Our study showed that patients with COVID-19 who presented with LI had a significantly increased risk of mortality and poor clinical outcomes.
Literatur
1.
Zurück zum Zitat Dong Y, Liang X, Yu X. Prognostic value of the dynamic changes in extra vascular lung water index and angiopoietin-2 in severe multiple trauma patients with acute respiratory distress syndrome [in Chinese]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2019;31:571–576.PubMed Dong Y, Liang X, Yu X. Prognostic value of the dynamic changes in extra vascular lung water index and angiopoietin-2 in severe multiple trauma patients with acute respiratory distress syndrome [in Chinese]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2019;31:571–576.PubMed
2.
Zurück zum Zitat Niu P, Shen J, Zhu N, Lu R, Tan W. Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses. Virol Sin. 2016;31:85–88.CrossRef Niu P, Shen J, Zhu N, Lu R, Tan W. Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses. Virol Sin. 2016;31:85–88.CrossRef
4.
Zurück zum Zitat Chau TN, Lee KC, Yao H et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004;39:302–310.CrossRef Chau TN, Lee KC, Yao H et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004;39:302–310.CrossRef
5.
Zurück zum Zitat Hu LL, Wang WJ, Zhu QJ, Yang L. Novel coronavirus pneumonia related liver injury: etiological analysis and treatment strategy [in Chinese]. Zhonghua Gan Zang Bing Za Zhi 2020;28:97–99.PubMed Hu LL, Wang WJ, Zhu QJ, Yang L. Novel coronavirus pneumonia related liver injury: etiological analysis and treatment strategy [in Chinese]. Zhonghua Gan Zang Bing Za Zhi 2020;28:97–99.PubMed
6.
Zurück zum Zitat Zu ZY, Jiang MD, Xu PP et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology. 2020;296:E15–E25.CrossRef Zu ZY, Jiang MD, Xu PP et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology. 2020;296:E15–E25.CrossRef
7.
Zurück zum Zitat Mao R, Liang J, Shen J et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020;5:425–427.CrossRef Mao R, Liang J, Shen J et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020;5:425–427.CrossRef
8.
Zurück zum Zitat Chai X, Hu L, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv. 2020;2020.02.03.931766. Chai X, Hu L, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv. 2020;2020.02.03.931766.
9.
Zurück zum Zitat Killerby ME, Link-Gelles R, Haight SC et al. Characteristics associated with hospitalization among patients with COVID-19 - metropolitan Atlanta, Georgia, March–April 2020. MMWR Morb Mortal Wkly Rep. 2020;69:790–794.CrossRef Killerby ME, Link-Gelles R, Haight SC et al. Characteristics associated with hospitalization among patients with COVID-19 - metropolitan Atlanta, Georgia, March–April 2020. MMWR Morb Mortal Wkly Rep. 2020;69:790–794.CrossRef
10.
Zurück zum Zitat Millett GA, Jones AT, Benkeser D et al. Assessing differential impacts of COVID-19 on black communities. Ann Epidemiol. 2020;47:37–44.CrossRef Millett GA, Jones AT, Benkeser D et al. Assessing differential impacts of COVID-19 on black communities. Ann Epidemiol. 2020;47:37–44.CrossRef
11.
Zurück zum Zitat Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and mortality among black patients and white patients with Covid-19. N Engl J Med. 2020;382:2534–2543.CrossRef Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and mortality among black patients and white patients with Covid-19. N Engl J Med. 2020;382:2534–2543.CrossRef
13.
Zurück zum Zitat Hao SR, Zhang SY, Lian JS et al. Liver enzyme elevation in coronavirus disease 2019: a multicenter, retrospective, cross-sectional study. Am J Gastroenterol. 2020;115:1075–1083.CrossRef Hao SR, Zhang SY, Lian JS et al. Liver enzyme elevation in coronavirus disease 2019: a multicenter, retrospective, cross-sectional study. Am J Gastroenterol. 2020;115:1075–1083.CrossRef
14.
Zurück zum Zitat Phipps MM, Barraza LH, LaSota ED et al. Acute liver injury in COVID-19: prevalence and association with clinical outcomes in a large US cohort. Hepatology. 2020;72:807–817.CrossRef Phipps MM, Barraza LH, LaSota ED et al. Acute liver injury in COVID-19: prevalence and association with clinical outcomes in a large US cohort. Hepatology. 2020;72:807–817.CrossRef
15.
Zurück zum Zitat Jiang S, Wang R, Li L et al. Liver injury in critically ill and non-critically Ill COVID-19 patients: a multicenter, retrospective, observational study. Front Med (Lausanne). 2020;7:347.CrossRef Jiang S, Wang R, Li L et al. Liver injury in critically ill and non-critically Ill COVID-19 patients: a multicenter, retrospective, observational study. Front Med (Lausanne). 2020;7:347.CrossRef
16.
Zurück zum Zitat Kovalic AJ, Satapathy SK, Thuluvath PJ. Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis. Hepatol Int. 2020;14:612–620.CrossRef Kovalic AJ, Satapathy SK, Thuluvath PJ. Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis. Hepatol Int. 2020;14:612–620.CrossRef
18.
Zurück zum Zitat Peiris JSM, Yuen KY, Osterhaus ADME, Stöhr K. The severe acute respiratory syndrome. N Engl J Med. 2003;349:2431–2441.CrossRef Peiris JSM, Yuen KY, Osterhaus ADME, Stöhr K. The severe acute respiratory syndrome. N Engl J Med. 2003;349:2431–2441.CrossRef
19.
Zurück zum Zitat Farcas GA, Poutanen SM, Mazzulli T et al. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis. 2005;191:193–197.CrossRef Farcas GA, Poutanen SM, Mazzulli T et al. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis. 2005;191:193–197.CrossRef
20.
Zurück zum Zitat Tan YJ, Fielding BC, Goh PY et al. Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway. J Virol. 2004;78:14043–14047.CrossRef Tan YJ, Fielding BC, Goh PY et al. Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway. J Virol. 2004;78:14043–14047.CrossRef
21.
Zurück zum Zitat Chan JFW, Kok KH, Zhu Z et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9:221–236 (Published correction appears in Emerg Microbes Infect. 2020;9:540).CrossRef Chan JFW, Kok KH, Zhu Z et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9:221–236 (Published correction appears in Emerg Microbes Infect. 2020;9:540).CrossRef
22.
Zurück zum Zitat Alqahtani SA, Schattenberg JM. Liver injury in COVID-19: the current evidence. United European Gastroenterol J. 2020;8:509–519.CrossRef Alqahtani SA, Schattenberg JM. Liver injury in COVID-19: the current evidence. United European Gastroenterol J. 2020;8:509–519.CrossRef
23.
Zurück zum Zitat Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20:269–270.CrossRef Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20:269–270.CrossRef
24.
Zurück zum Zitat Li L, Li S, Xu M, et al. Risk factors related to hepatic injury in patients with corona virus disease 2019. medRxiv. 2020;2020.02.28.20028514. Li L, Li S, Xu M, et al. Risk factors related to hepatic injury in patients with corona virus disease 2019. medRxiv. 2020;2020.02.28.20028514.
25.
Zurück zum Zitat Cai Q, Huang D, Ou P et al. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy 2020;75:1742–1752.CrossRef Cai Q, Huang D, Ou P et al. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy 2020;75:1742–1752.CrossRef
26.
Zurück zum Zitat Xu Z, Shi L, Wang Y et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–422 (Published correction appears in Lancet Respir Med. 2020;8:e26).CrossRef Xu Z, Shi L, Wang Y et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–422 (Published correction appears in Lancet Respir Med. 2020;8:e26).CrossRef
Metadaten
Titel
Increased Morbidity and Mortality in COVID-19 Patients with Liver Injury
verfasst von
Mohammad Arsalan Siddiqui
Suraj Suresh
Stephen Simmer
Mouhanna Abu-Ghanimeh
Megan Karrick
Faisal Nimri
Maher Musleh
Vivek Mediratta
Mustafa Al-Shammari
Sarah Russell
Jessica Jou
Duyen Dang
Reena Salgia
Tobias Zuchelli
Publikationsdatum
04.05.2021
Verlag
Springer US
Schlagwort
COVID-19
Erschienen in
Digestive Diseases and Sciences / Ausgabe 6/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07007-0

Weitere Artikel der Ausgabe 6/2022

Digestive Diseases and Sciences 6/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.